Modulation of the Cellular Expression of Circulating Advanced Glycation End-Product Receptors in Type 2 Diabetic Nephropathy

Experimental Diabetes Research

Volumn 2010, Issue , 2010, Pages

  Sourris, Karly C ^a   Harcourt, Brooke E ^a,b   Penfold, Sally A ^a   Yap, Felicia Y T ^a   Morley, Amy L ^a   Morgan, Philip E ^c,d   Davies, Michael J ^c,d   Baker, Scott T ^e,f   Jerums, George ^e,f   Forbes, Josephine M ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c HEART RESEARCH INSTITUTE   (Australia)

^d University of Sydney   (Australia)

^e AUSTIN HEALTH   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ADVANCED GLYCATION END PRODUCT RECEPTOR 1; ADVANCED GLYCATION END PRODUCT RECEPTOR 3; ALBUMIN; UNCLASSIFIED DRUG; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FLOW CYTOMETRY; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN CELL; KIDNEY DYSFUNCTION; MALE; METABOLIC SYNDROME X; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BLOOD; C57BL MOUSE;

ANIMALS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FLOW CYTOMETRY; GLYCOSYLATION END PRODUCTS, ADVANCED; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, IMMUNOLOGIC;

EID: 79952296478     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2010/974681     Document Type: Article

References (35)

1. Brownlee M., Vlassara H., Kooney A., Ulrich P., Cerami A., Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking Science 1986 232 4758 1629 1632 (Pubitemid 16095602)
2. Sourris K. C., Forbes J. M., Interactions between Advanced Glycation End-products (AGE) and their receptors in the development and progression of diabetic nephropathyare these receptors valid therapeutic targets Current Drug Targets 2009 10 1 42 50
3. Bierhaus A., Hofmann M. A., Ziegler R., Nawroth P. P., AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept Cardiovascular Research 1998 37 3 586 600 (Pubitemid 28231153)
4. Wendt T. M., Tanji N., Guo J., Kislinger T. R., Qu WU., Lu Y., Bucciarelli L. G., Ling Rong L., Moser B., Markowitz G. S., Stein G., Bierhaus A., Liliensiek B., Arnold B., Nawroth P. P., Stern D. M., D'Agati V. D., Schmidt A. M., RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy American Journal of Pathology 2003 162 4 1123 1137 (Pubitemid 36350658)
5. Wautier J. L., Guillausseau P. J., Advanced glycation end products, their receptors and diabetic angiopathy Diabetes and Metabolism 2001 27 5 535 542 (Pubitemid 33051702)
6. Schmidt A. M., Hori O., Brett J., Shi Du Yan., Wautier J. L., Stern D., Cellular receptors for advanced glycation end products: implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions Arteriosclerosis and Thrombosis 1994 14 10 1521 1528
7. Yonekura H., Yamamoto Y., Sakurai S., Watanabe T., Yamamoto H., Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury Journal of Pharmacological Sciences 2005 97 3 305 311 (Pubitemid 40515743)
8. Bierhaus A., Humpert P. M., Morcos M., Wendt T., Chavakis T., Arnold B., Stern D. M., Nawroth P. P., Understanding RAGE, the receptor for advanced glycation end products Journal of Molecular Medicine 2005 83 11 876 886 (Pubitemid 41598688)
9. Cai W., He J. C., Zhu L., Chen X., Zheng F., Striker G. E., Vlassara H., Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan American Journal of Pathology 2008 173 2 327 336
10. Buchs A. E., Kornberg A., Zahavi M., Aharoni D., Zarfati C., Rapoport M. J., Increased expression of tissue factor and receptor for advanced glycation end products in peripheral blood mononuclear cells of patients with type 2 diabetes mellitus with vascular complications Experimental Diabesity Research 2004 5 2 163 169 (Pubitemid 38868241)
11. Soulis T., Thallas V., Youssef S., Gilbert R. E., McWilliam B. G., Murray-McIntosh R. P., Cooper M. E., Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury Diabetologia 1997 40 6 619 628 (Pubitemid 27288105)
12. Silberstein S., Kelleher D. J., Gilmore R., The 48-kDa subunit of the mammalian oligosaccharyltransferase complex is homologous to the essential yeast protein WBP1 The Journal of Biological Chemistry 1992 267 33 23658 23663 (Pubitemid 23088169)
13. Cai W., He J. C., Zhu L., Chen X., Striker G. E., Vlassara H., AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66-dependent FKHRL1 phosphorylation American Journal of Physiology 2008 294 1 C145 C152
14. Li Y. M., Mitsuhashi T., Wojciechowicz D., Shimizu N., Li J., Stitt A., He C., Banerjee D., Vlassara H., Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins Proceedings of the National Academy of Sciences of the United States of America 1996 93 20 11047 11052 (Pubitemid 26333115)
15. Lu C., He J. C., Cai W., Liu H. I., Zhu LI., Vlassara H., Advanced glycation product (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells Proceedings of the National Academy of Sciences of the United States of America 2004 101 32 11767 11772 (Pubitemid 39099304)
16. Cai W., He J. C., Zhu L., Lu C., Vlassara H., Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor Proceedings of the National Academy of Sciences of the United States of America 2006 103 37 13801 13806 (Pubitemid 44413988)
17. He C. J., Zheng F., Stitt A., Striker L., Hattori M., Vlassara H., Differential expression of renal AGE-receptor genes in NOD mice: possible role in nonobese diabetic renal disease Kidney International 2000 58 5 1931 1940
18. Coughlan M. T., Thallas-Bonke V., Pete J., Long D. M., Gasser A., Tong D. C. K., Arnstein M., Thorpe S. R., Cooper M. E., Forbes J. M., Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy? Endocrinology 2007 148 2 886 895 (Pubitemid 46143188)
19. He C. J., Koschinsky T., Buenting C., Vlassara H., Presence of diabetic complications in type 1 diabetic patients correlates with low expression of mononuclear cell AGE-receptor-1 and elevated serum AGE Molecular Medicine 2001 7 3 159 168 (Pubitemid 33701987)
20. Iacobini C., Amadio L., Oddi G., Ricci C., Barsotti P., Missori S., Sorcini M., Di Mario U., Pricci F., Pugliese G., Role of galectin-3 in diabetic nephropathy Journal of the American Society of Nephrology 2003 14 3 S264 S270
21. Pugliese G., Pricci F., Leto G., Amadio L., Iacobini C., Romeo G., Lenti L., Sale P., Gradini R., Liu FU. T., Di Mario U., The diabetic milieu modulates the advanced glycation end product- receptor complex in the mesangium by inducing or upregulating galectin-3 expression Diabetes 2000 49 7 1249 1257 (Pubitemid 30439102)
22. Krzelak A., Lipinka A., Galectin-3 as a multifunctional protein Cellular and Molecular Biology Letters 2004 9 2 305 328
23. Zeng J., Davies M. J., Evidence for the formation of adducts and S-(carboxymethyl)cysteine on reaction of -dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins Chemical Research in Toxicology 2005 18 8 1232 1241 (Pubitemid 41170247)
24. Jerums G., Allen T. J., Campbell D. J., Cooper M. E., Gilbert R. E., Hammond J. J., Raffaele J., Tsalamandris C., Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria American Journal of Kidney Diseases 2001 37 5 890 899 (Pubitemid 32471847)
25. Pachydaki S. I., Tari S. R., Lee S. E., Ma W., Tseng J. J., Sosunov A. A., Cataldergirmen G., Scarmeas N., Caspersen C., Chang S., Schiff W. M., Schmidt A. M., Barile G. R., Upregulation of RAGE and its ligands in proliferative retinal disease Experimental Eye Research 2006 82 5 807 815 (Pubitemid 43170881)
26. Perkins B. A., Ficociello L. H., Roshan B., Warram J. H., Krolewski A. S., In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria Kidney International 2010 77 1 57 64
27. Ziyadeh F. N., Hoffman B. B., Han D. C., Iglesias-De La Cruz M. C., Hong S. W., Isono M., Chen S., McGowan T. A., Sharma K., Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor- antibody in db/db diabetic mice Proceedings of the National Academy of Sciences of the United States of America 2000 97 14 8015 8020 (Pubitemid 30460765)
28. Vlassara H., Cai W., Crandall J., Goldberg T., Oberstein R., Dardaine V., Peppa M., Rayfield E. J., Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy Proceedings of the National Academy of Sciences of the United States of America 2002 99 24 15596 15601 (Pubitemid 35403978)
29. Baynes J. W., Chemical modification of proteins by lipids in diabetes Clinical Chemistry and Laboratory Medicine 2003 41 9 1159 1165 (Pubitemid 37265694)
30. Cai W., He J. C., Zhu L., Chen X., Wallenstein S., Striker G. E., Vlassara H., Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression American Journal of Pathology 2007 170 6 1893 1902 (Pubitemid 47339263)
31. Hofmann S. M., Dong H. J., Li Z., Cai W., Altomonte J., Thung S. N., Zeng F., Fisher E. A., Vlassara H., Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse Diabetes 2002 51 7 2082 2089 (Pubitemid 34729011)
32. Knauer R., Lehle L., The N-oligosaccharyltransferase complex from yeast FEBS Letters 1994 344 1 83 86 (Pubitemid 24147312)
33. Men P., Festuccia F., Polci R., Pugliese F., Cinotti G. A., Diabetic nephropathy and advanced glycation end products Contributions to Nephrology 2001 131 22 32 (Pubitemid 33816226)
34. Pricci F., Leto G., Amadio L., Iacobini C., Romeo G., Cordone S., Gradini R., Barsotti P., Liu F. T., Di Mario U., Pugliese G., Role of galectin-3 as a receptor for advanced glycosylation end products Kidney International, Supplement 2000 58 77 S31 S39
35. Iacobini C., Menini S., Oddi G., Ricci C., Amadio L., Pricci F., Olivieri A., Sorcini M., Di Mario U., Pesce C., Pugliese G., Galectin-3/AGE-receptor 3 knockout mice show accelerated AGE-induced glomerular injury: evidence for a protective role of galectin-3 as an AGE receptor FASEB Journal 2004 18 14 1773 1775 (Pubitemid 39561680)